Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 5, 2002
A phase II study evaluating the tolerability and efficacy of CAELYX (liposomal doxorubicin, Doxil) in the treatment of unresectable pancreatic carcinomaS Halford, D Yip, C S Karapetis, et al.
British Journal of Cancer|May 20, 2015
Meta-analysis of BRAF mutation as a predictive biomarker of benefit from anti-EGFR monoclonal antibody therapy for RAS wild-type metastatic colorectal cancerA Rowland, M M Dias, M D Wiese, et al.
Internal Medicine Journal|February 5, 2015
Delayed onset of benign pleural effusion following concurrent chemoradiotherapy for inoperable non-small-cell lung cancerR Kumar, G Patel, G Kichenadasse, et al.
Internal Medicine Journal|July 9, 2016
Goserelin toxicities and preferences for ovarian suppression method in pre-menopausal women with breast cancerA H-C Hsieh, G Kichenadasse, S Vatandoust, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
Circulating tumour DNA and MRI circumferential resection margin are key prognostic indicators for survival in rectal cancerA Roy, M Shepherdson, K Gormly, et al.
European Journal of Cancer Care|June 4, 2016
Colorectal cancer treatment and survival over three decades at four major public hospitals in South Australia: trends by age and in the elderlyD Roder, C S Karapetis, D Wattchow, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 5, 2013
Final results of Australasian Gastrointestinal Trials Group ARCTIC study: an audit of raltitrexed for patients with cardiac toxicity induced by fluoropyrimidinesD Ransom, K Wilson, M Fournier, et al.
British Journal of Cancer|July 18, 2013
Do metastatic colorectal cancer patients who present with late relapse after curative surgery have a better survival?V T Broadbridge, C S Karapetis, C Beeke, et al.
The Pharmacogenomics Journal|November 30, 2016
Germline polymorphisms as biomarkers of tumor response in colorectal cancer patients treated with anti-EGFR monoclonal antibodies: a systematic review and meta-analysisE K Morgen, H-J Lenz, D J Jonker, et al.
British Journal of Cancer|November 8, 2006
Gemcitabine and carboplatin in carcinoma of unknown primary site: a phase 2 Adelaide Cancer Trials and Education Collaborative studyK B Pittman, I N Olver, B Koczwara, et al.
Pageof 4